Uptravi 800 MCG tablet 60S

Ended Awarded

Contract number
SPE2DR26FCPS8
Awardee
Awarding agency
Obligated
$74,123

Award facts

Contract value 100% obligated
$74,122.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $74,122.56 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 17, 2026, for UPTRAVI 800 MCG tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency carrying a $499.999 billion ceiling through December 31, 2036. PPV-G GEN V is a 30-month base period with three 30-month option periods. Place of performance is Park Ridge, Illinois. The delivery order has a firm fixed price and an ultimate completion date of July 10, 2026. No set-aside applies.

Quick answers

Who was awarded contract SPE2DR26FCPS8?

SPE2DR26FCPS8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 17, 2026.

How much is contract SPE2DR26FCPS8 worth?

The government has obligated $74,123 on SPE2DR26FCPS8.

Is contract SPE2DR26FCPS8 an order under another contract?

Yes. SPE2DR26FCPS8 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.

Was contract SPE2DR26FCPS8 competed?

The extent of competition for SPE2DR26FCPS8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award